Fighting a Bad Bug

Published Online: Monday, January 30, 2012
Follow Pharmacy_Times:
In this podcast from the Centers for Disease Control and Prevention's (CDC's) Morbidity and Mortality Weekly Report, Dr. Pekka Nuorti, medical epidemiologist with the National Center for Immunization and Respiratory Diseases, discusses the effectiveness of the pneumococcal conjugate vaccine.

Click here to listen to the interview, which was recorded as part of the A Cup of Health with CDC series.
Related Articles
A reduction in pediatric health care visits related to otitis media between 2001 and 2011 appears to be due to uptake of the pneumococcal conjugate vaccine, according to the results of a new study.
A new study finds that decreased rates of infection with serotypes of pneumococcal disease the PCV7 vaccine protects against outweigh increased rates of infection with serotypes it does not protect against.
Streptococcus pneumoniae is the leading cause of life-threatening illness globally.
A decade after the 7-valent pneumococcal conjugate vaccine was introduced, it led to approximately 168,000 fewer annual hospitalizations for pneumonia.
Latest Issues